Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
27.80
Nov 12 • 9:40 AM ET Dollar change-0.12 Percentage change(-0.45%)
Category
US Equities - Industry Sector
Sponsor
REX Shares
Fund Family
Index
VettaFi Peptide Index
Index Weighting
Active/Passive
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Expense
0.65%
Inverse/Leveraged
IPO
Oct 14, 2026
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
No / Yes
Tags
Tags
Tags
Tags
Tags
Tags
Tags
Sector/Theme
Region
SMA20
4.17%
SMA50
4.66%
SMA200
4.66%
Return% 1Y
-
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
378.63%
Flows% 3M
378.63%
Flows% YTD
378.63%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
35
AUM
3.34M
NAV/sh
52W High
28.14 -1.21%
52W Low
25.06 10.95%
Volatility
1.86% -
ATR (14)
0.47
RSI (14)
70.24
Beta
-
Rel Volume
1.22
Avg Volume
6.89K
Volume
627
Perf Week
3.08%
Perf Month
10.95%
Perf Quarter
-
Perf Half Y
-
Perf YTD
10.80%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
27.92
Price
27.80
Change %
-0.45%
Oct-21-26 12:01AM
REX Peptide ETF tracks the investment results of the VettaFi Peptide Index, designed to measure the performance of equity securities of companies strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products and enabling technologies. The fund employs a replication strategy to track companies operating primarily across pharmaceuticals, biotechnology, life sciences, healthcare, supplements, cosmetics, and medical devices.